Table 1

Participant information

ID†Site*Age (Years)Previous breast cancer treatmentCurrent breast cancer treatmentBreast reconstruction receivedType of reconstruction
105355–59Mastectomy,
adjuvant chemotherapy
YesDBR—autologous
106340–44Lumpectomy,
adjuvant chemoradiation
MastectomyYesIBR—prosthetic
107355–59LumpectomyMastectomyYesDBR—autologous
108350–54LumpectomyMastectomyYesIBR—prosthetic
109365–69Mastectomy,
adjuvant chemotherapy
YesDBR—autologous
110455–59Mastectomy,
adjuvant chemoradiation
No
111645–49MastectomyYesDBR—prosthetic
112160–64Neoadjuvant chemotherapy, pending mastectomyNo
113350–54LumpectomyMastectomyYesIBR—prosthetic
114155–59Neoadjuvant chemotherapy, pending mastectomyNo
115650–54Mastectomy,
adjuvant chemotherapy
No
116665–69LumpectomyMastectomyYesDBR—prosthetic
117Organisation40–44Lumpectomy,
adjuvant chemoradiation
Pending mastectomyNo
118Organisation30–34Neoadjuvant chemotherapy, mastectomy,
adjuvant radiotherapy
No
119Organisation40–44Mastectomy,
adjuvant chemoradiation
No
120155–59 — —
121Organisation25–29Neoadjuvant chemotherapy, pending mastectomyNo
122435–39Mastectomy,
adjuvant chemotherapy
No
123460–64Neoadjuvant chemotherapy, pending mastectomyNo
124250–54Pending mastectomyNo
125455–59Pending mastectomyNo
126455–59Pending mastectomyNo
127645–49LumpectomyMastectomy, adjuvant radiotherapyNo
128555–59Mastectomy,
adjuvant chemoradiation
No
129625–29Mastectomy,
adjuvant chemotherapy
YesDBR—prosthetic
130525–29MastectomyYesIBR—autologous
131640–44LumpectomyMastectomyYesIBR—prosthetic
132Organisation50–54Mastectomy,
adjuvant chemotherapy
No
  • *Sites 1–4 are high volume centres. Sites 5 and 6 are small volume centres.

  • †ID 100–104 were pilot test interviews to refine interviewing strategies.

  • DBR, delayed breast reconstruction; IBR, immediate breast reconstruction.